Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1980
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Remarks:
Non GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
full LD50 performed
GLP compliance:
no
Test type:
other: LD50
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium nitrate
EC Number:
231-554-3
EC Name:
Sodium nitrate
Cas Number:
7631-99-4
Molecular formula:
HNO3.Na
IUPAC Name:
sodium nitrate
Test material form:
solid
Details on test material:
- Name of test material (as cited in study report): Natronsalpeter (Sodium Nitrate)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: WIGA
- Weight at study initiation: 230-250 (males), 170-190 (females)
- Fasting period before study: 15-20 h
- Diet: Herilan MRH-Haltung, H. Eggersmann KG

IN-LIFE DATES: From: 2 Oct 1980 To: 22 Oct 1980

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 68.1, 46.4, 31.6, 21.5, 14.7 %

DOSE VOLUME APPLIED: 10 mL/kg
Doses:
6810, 4640, 3160, 2150, 1470 mg/kg body weight
No. of animals per sex per dose:
5 males, 5 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of weighing: Before start, Day 2-4, Day 7, Day 13
- Necropsy of survivors performed: yes
- Other examinations performed: histopathology of liver of dead animals
Statistics:
Probit analysis (Finney)

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
ca. 3 430 mg/kg bw
Mortality:
6810 mg/kg body weight: 5 males, 5 females died
4640 mg/kg body weight: 5 males, 4 females died
3160 mg/kg body weight: 1 males, 3 females died
2150 mg/kg body weight: 0 males, 0 females died
1470 mg/kg body weight: 0 males, 0 females died
Clinical signs:
other: dyspnoe, apathy, abnormal posture, ataxia, atonia, pain reflex absent, cornea reflex absent, comatose condition, spasms, tremor, piloerection, trismus, cyanosis, dehydration, ptosis, paresis, poor general condition
Gross pathology:
heart: acute congestion,
lungs: multiple acute dilations. discolouration
stomach: red discolouration of glandular stomach, , bloody ulceration or large bleedings
intestine: atonia, diarrhoea,
kidney: pallor
Other findings:
histology liver: vacuolar degeneration

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Remarks:
Not classified according to Regulation (EC) 1272/2008
Conclusions:
LD50 = 3500 mg/kg (males)
LD50 = 3200 mg/kg (females)
LD50 = 3430 mg/kg (males and females combined)